Exploring Transcriptomic Databases: Unraveling Circadian Gene Disruptions in Lower Grade Glioma

Overview

Journal Sci Rep

Specialty Science

Date 2024 Jul 23

PMID 39043735

Authors

Weiyu Hou

Weiming Hou

Xueming Zhao

Affiliations

Soon will be listed here.

Abstract

The study explored the role of circadian rhythm genes (CRGs) in lower grade glioma (LGG) development and found that certain genes, such as CRY1, NPAS2, and RORB, were associated with increased or decreased risk of LGG. The study also investigated the correlation between CRGs and immune cell infiltration, revealing a negative association with macrophage infiltration and a positive correlation with B cell and CD8 + T cell infiltration. Additionally, the study identified major mutated CRGs, including PER2, BMAL1, CLOCK, and BMAL2, and their potential interaction with other CNS-associated genes. The study suggests that CRGs play a crucial role in immune response and tumorigenesis in LGG patients and warrants further investigation.

References

Chen T, Zhang H, Liu Y, Liu Y, Huang L . EVenn: Easy to create repeatable and editable Venn diagrams and Venn networks online. J Genet Genomics. 2021; 48(9):863-866. DOI: 10.1016/j.jgg.2021.07.007. View

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1):W98-W102. PMC: 5570223. DOI: 10.1093/nar/gkx247. View

Li T, Fan J, Wang B, Traugh N, Chen Q, Liu J . TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res. 2017; 77(21):e108-e110. PMC: 6042652. DOI: 10.1158/0008-5472.CAN-17-0307. View

Schoof M, Epplen G, Walter C, Ballast A, Holdhof D, Gobel C . The tumor suppressor CREBBP and the oncogene MYCN cooperate to induce malignant brain tumors in mice. Oncogenesis. 2023; 12(1):36. PMC: 10322855. DOI: 10.1038/s41389-023-00481-3. View

Takashima Y, Kawaguchi A, Sato R, Yoshida K, Hayano A, Homma J . Differential expression of individual transcript variants of PD-1 and PD-L2 genes on Th-1/Th-2 status is guaranteed for prognosis prediction in PCNSL. Sci Rep. 2019; 9(1):10004. PMC: 6620277. DOI: 10.1038/s41598-019-46473-5. View

Zhu L, Wang Q, Hu Y, Wang F . The Circadian Gene Per1 Plays an Important Role in Radiation-Induced Apoptosis and DNA Damage in Glioma. Asian Pac J Cancer Prev. 2019; 20(7):2195-2201. PMC: 6745214. DOI: 10.31557/APJCP.2019.20.7.2195. View

Takashima Y, Kawaguchi A, Iwadate Y, Hondoh H, Fukai J, Kajiwara K . miR-101, miR-548b, miR-554, and miR-1202 are reliable prognosis predictors of the miRNAs associated with cancer immunity in primary central nervous system lymphoma. PLoS One. 2020; 15(2):e0229577. PMC: 7043771. DOI: 10.1371/journal.pone.0229577. View

Cerami E, Gao J, Dogrusoz U, Gross B, Sumer S, Aksoy B . The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012; 2(5):401-4. PMC: 3956037. DOI: 10.1158/2159-8290.CD-12-0095. View

Li X, Ji C, Gu J, Xu J, Jin Z, Sun L . Molecular cloning and characterization of AAAS-V2, a novel splice variant of human AAAS. Mol Biol Rep. 2005; 32(2):127-31. DOI: 10.1007/s11033-004-6939-9. View

10.

Handschug K, Sperling S, Yoon S, Hennig S, Clark A, Huebner A . Triple A syndrome is caused by mutations in AAAS, a new WD-repeat protein gene. Hum Mol Genet. 2001; 10(3):283-90. DOI: 10.1093/hmg/10.3.283. View

11.

Li B, Severson E, Pignon J, Zhao H, Li T, Novak J . Comprehensive analyses of tumor immunity: implications for cancer immunotherapy. Genome Biol. 2016; 17(1):174. PMC: 4993001. DOI: 10.1186/s13059-016-1028-7. View

12.

Lin W, Ou G, Zhao W . Mutational profiling of low-grade gliomas identifies prognosis and immunotherapy-related biomarkers and tumour immune microenvironment characteristics. J Cell Mol Med. 2021; 25(21):10111-10125. PMC: 8572778. DOI: 10.1111/jcmm.16947. View

13.

Petkovic M, Yalcin M, Heese O, Relogio A . Differential expression of the circadian clock network correlates with tumour progression in gliomas. BMC Med Genomics. 2023; 16(1):154. PMC: 10316603. DOI: 10.1186/s12920-023-01585-w. View

14.

Abdelfattah N, Kumar P, Wang C, Leu J, Flynn W, Gao R . Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target. Nat Commun. 2022; 13(1):767. PMC: 8828877. DOI: 10.1038/s41467-022-28372-y. View

15.

Shafi A, McNair C, McCann J, Alshalalfa M, Shostak A, Severson T . The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair. Nat Commun. 2021; 12(1):401. PMC: 7810852. DOI: 10.1038/s41467-020-20513-5. View

16.

Sancar A, Lindsey-Boltz L, Gaddameedhi S, Selby C, Ye R, Chiou Y . Circadian clock, cancer, and chemotherapy. Biochemistry. 2014; 54(2):110-23. PMC: 4303322. DOI: 10.1021/bi5007354. View

17.

Sturm G, Finotello F, Petitprez F, Zhang J, Baumbach J, Fridman W . Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology. Bioinformatics. 2019; 35(14):i436-i445. PMC: 6612828. DOI: 10.1093/bioinformatics/btz363. View

18.

Takashima Y, Kawaguchi A, Fukai J, Iwadate Y, Kajiwara K, Hondoh H . Survival prediction based on the gene expression associated with cancer morphology and microenvironment in primary central nervous system lymphoma. PLoS One. 2021; 16(6):e0251272. PMC: 8224980. DOI: 10.1371/journal.pone.0251272. View

19.

Takashima Y, Kawaguchi A, Kanayama T, Hayano A, Yamanaka R . Correlation between lower balance of Th2 helper T-cells and expression of PD-L1/PD-1 axis genes enables prognostic prediction in patients with glioblastoma. Oncotarget. 2018; 9(27):19065-19078. PMC: 5922378. DOI: 10.18632/oncotarget.24897. View

20.

Hemani G, Zheng J, Elsworth B, Wade K, Haberland V, Baird D . The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018; 7. PMC: 5976434. DOI: 10.7554/eLife.34408. View